mRNA |
AT13387 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
0.0001 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.12 |
0.0001 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.11 |
0.0001 |
mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0001 |
mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
0.14 |
0.0002 |
mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.0002 |
mRNA |
XMD13-2 |
GDSC1000 |
pan-cancer |
AAC |
0.12 |
0.0002 |
mRNA |
Camptothecin |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
0.13 |
0.0002 |